04/25/2024
3:01 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:06 PM | Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/19/2024
5:05 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
8:31 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
5:10 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
5:05 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/01/2024
8:16 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/01/2024
7:15 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
7:54 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
7:55 PM | Brainstorm Cell Therapeutics (Issuer)
Patlis Alla (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
7:56 PM | Brainstorm Cell Therapeutics (Issuer)
Yablonka Uri (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
7:57 PM | Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
9:06 AM | Brainstorm Cell Therapeutics (Subject)
Ness Kevin Dean (Filed by)
| Form SC 13G/A | |
12/20/2023
4:04 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
5:03 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
3:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
4:28 PM | Brainstorm Cell Therapeutics (Filer)
| Form DEF 14A | |
10/24/2023
6:30 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
4:16 PM | Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
6:31 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:31 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:21 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
5:02 AM | Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
8:28 AM | Brainstorm Cell Therapeutics (Filer)
| Form 424B5 | |
06/21/2023
3:05 PM | Brainstorm Cell Therapeutics (Issuer)
Naor Nir (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/21/2023
3:06 PM | Brainstorm Cell Therapeutics (Issuer)
Naor Nir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:58 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
6:30 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2023
6:15 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
